These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2416387)

  • 61. Endplate channel actions of a hemicholinium-3 analog, DMAE.
    Alkadhi KA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):230-5. PubMed ID: 3012371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction.
    Gage PW; Lonergan M; Torda TA
    Br J Pharmacol; 1980 May; 69(1):119-21. PubMed ID: 6247003
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of analogs of histrionicotoxin with the acetylcholine receptor ionic channel complex and membrane excitability.
    Maleque MA; Brossi A; Witkop B; Godleski SA; Albuquerque EX
    J Pharmacol Exp Ther; 1984 Apr; 229(1):72-9. PubMed ID: 6323691
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1989 Sep; 250(3):842-52. PubMed ID: 2476549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
    Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
    Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
    Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.
    Van der Kloot W
    J Neurophysiol; 1987 May; 57(5):1536-54. PubMed ID: 3035113
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction.
    Gwilt M; Wray D
    Br J Pharmacol; 1986 May; 88(1):25-31. PubMed ID: 2423175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. On the mechanism of calcium actions on the acetylcholine receptor-channel complex at the frog end-plate membrane.
    Kuba K; Takeshita S
    Jpn J Physiol; 1983; 33(6):931-44. PubMed ID: 6325788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A kinetic analysis of the endplate ion channel blocking action of disopyramide and its optical isomers.
    Dempster J; Jones SV; Marshall IG
    Br J Pharmacol; 1987 Feb; 90(2):299-307. PubMed ID: 2435351
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction.
    Sellin LC; Thesleff S
    J Physiol; 1981 Aug; 317():487-95. PubMed ID: 6273549
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An analysis of the action of a false transmitter at the neuromuscular junction.
    Colquhoun D; Large WA; Rang HP
    J Physiol; 1977 Apr; 266(2):361-95. PubMed ID: 192885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanism of blockade of neuromuscular transmission by pentobarbital.
    Seyama I; Narahashi T
    J Pharmacol Exp Ther; 1975 Jan; 192(1):95-104. PubMed ID: 164531
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of an adenylate cyclase inhibitor on the electrophysiological correlates of neuromuscular transmission in the frog.
    Silinsky EM; Vogel SM
    Br J Pharmacol; 1986 Aug; 88(4):799-805. PubMed ID: 3017493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantal analysis indicates an alpha-toxin-like block by lophotoxin, a non-ionic marine natural product.
    Langdon RB; Jacobs RS
    Life Sci; 1983 Mar; 32(11):1223-8. PubMed ID: 6132312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of low temperature and terminal membrane potential on quantal size at frog neuromuscular junction.
    Cohen IS; Van der Kloot W
    J Physiol; 1983 Mar; 336():335-44. PubMed ID: 6308226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correlation of agonist structure with acetylcholine receptor kinetics: studies on the frog end-plate and on chick embryo muscle.
    Auerbach A; del Castillo J; Specht PC; Titmus M
    J Physiol; 1983 Oct; 343():551-68. PubMed ID: 6315923
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog.
    Alkadhi K; Branisteanu DD; Henderson EG; Lambert JJ; Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):117-21. PubMed ID: 6157110
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of end-plate conductance in transected frog muscle: modification by drugs.
    Lambert JJ; Durant NN; Reynolds LS; Volle RL; Henderson EG
    J Pharmacol Exp Ther; 1981 Jan; 216(1):62-9. PubMed ID: 6969798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.